- Estimated deadline
- Nov 10, 2026
- Expected posting
- Mar 16, 2026
- Award size
- Not listed
- Total program funding
- Not listed
- Expected awards
- Not listed
- Cost sharing
- Not required
- Funding type
- Other
- Category
- Health
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
The National Institute of Neurological Disorders and Stroke (NINDS), in conjunction with additional Institutes/Centers (ICs)at the National Institutes of Health seek to support projects proposing Clinical Trials and Ancillary Studies that are conducted within NIH-Funded Clinical Trial Research Networks.
The program will encourage applications for multi-center clinical trials to be conducted within an established Clinical Trial Research Network funded by one of multiple NIH Institutes and Centers. Following peer review, the IC will prioritize studies to be conducted within the established network infrastructure with cooperative oversight by the administering IC. The program will use the bi-phasic, milestone driven UG3/UH3 cooperative agreement activity code. Awards will initially support an up to 2- year milestone-driven planning and start-up phase, with possible transition to an implementation (UH3) phase of up to 5 additional years.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. For additional information, potential applicants are encouraged to contact program staff listed below.
Who can apply
- Public and Indian housing authorities
- Other (see eligibility)
- Nonprofits without 501(c)(3) status
- Other Native American tribal organizations
- Independent school districts
- County governments
- City or township governments
- Private universities
- Federally recognized tribal governments
- Nonprofits with 501(c)(3) status
- Small businesses
- Public and state universities
- For-profit organizations
- State governments
- Special district governments
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Agency contact
NINDS Division of Clinical Research (DCR)
Please contact via e-mail.
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from NIH
All NIH funding- Closes in 1 dayRFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Deadline Oct 30, 2026(1d)Up to $1.3M
- Closes in 1 dayRFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Deadline Oct 30, 2026(1d)Up to $500K
- Closes in 1 dayRFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Deadline Oct 30, 2026(1d)Up to $2.3M
- Closes in 1 dayPAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline Oct 30, 2026(1d)
- Closes in 4 daysPAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline Nov 2, 2026(4d)
- Closes in 4 daysPAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline Nov 2, 2026(4d)
Get new funding every Monday
New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Mar 26, 2026. Deadlines and requirements can change: always confirm them in the official notice and the agency's page.